Connect
MJA
MJA

Updated Creutzfeldt–Jakob disease infection control guidelines: sifting facts from fiction

Ann P Koehler, Eugene Athan and Steven J Collins
Med J Aust 2013; 198 (5): 245-246. || doi: 10.5694/mja13.10114
Published online: 18 March 2013

New guidelines aimed at reducing iatrogenic disease and discrimination against patients

Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disorder which causes the death of about 25–30 Australians each year, giving an average mortality rate of 1.2 cases/million/year.1 It is untreatable. CJD is the commonest human form of prion disease2 and is a notifiable disease in all Australian states and territories, with notification to the relevant jurisdictional health department required for all cases in which a strong clinical suspicion for CJD exists.

  • Ann P Koehler1
  • Eugene Athan2
  • Steven J Collins3

  • 1 Communicable Disease Control Branch, SA Health, Adelaide, SA.
  • 2 Department of Infectious Diseases, Barwon Health, Geelong, VIC.
  • 3 Australian National Creutzfeldt–Jakob Disease Registry, University of Melbourne, Melbourne, VIC.


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.